Matches in Nanopublications for { ?s ?p "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP822782.RAAxRy73NBZjuNS5ELaVBgwq9BXXoSqcmb7Y-k7bNtMB0130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822782.RAAxRy73NBZjuNS5ELaVBgwq9BXXoSqcmb7Y-k7bNtMB0130_provenance.
- NP230537.RACyZ5_bs7qRcQOz8KMxcxuuAxjfeWR5AJTT3-6xeBm8c130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230537.RACyZ5_bs7qRcQOz8KMxcxuuAxjfeWR5AJTT3-6xeBm8c130_provenance.
- NP164600.RAUY9kQbhK7S8_tPhslQGQmlMEsDjxl0C1HysuvYZTXEY130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164600.RAUY9kQbhK7S8_tPhslQGQmlMEsDjxl0C1HysuvYZTXEY130_provenance.
- NP694901.RACaliUHOxbmvqmw_nnTzPuj209yQskcWNkQ6Gmig4Ryw130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694901.RACaliUHOxbmvqmw_nnTzPuj209yQskcWNkQ6Gmig4Ryw130_provenance.
- NP806849.RAkFuh8QlEq5dtXqjbT9hvN-ywmi-lZQ-uHmjAwQ-o8WE130_assertion description "[Lastly, the EMX2-high mRNA expressing group had statistically significant better recurrence-free survival (RFS) than the EMX2-low mRNA expression group in patients with adenocarcinoma (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806849.RAkFuh8QlEq5dtXqjbT9hvN-ywmi-lZQ-uHmjAwQ-o8WE130_provenance.